-
Mashup Score: 0
“European drug regulators find no evidence linking GLP-1 receptor agonists, including Ozempic and Wegovy, to suicidal thoughts or actions. Results from review o
Source: www.beckershospitalreview.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 26The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on weight loss following bariatric treatment: a systematic review and meta-analysis - 1 month(s) ago
AbstractContext. There has been growing recognition of the need for considering weight loss strategies following metabolic bariatric surgery (MBS) to limit the
Source: academic.oup.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 21
An “anti-hunger” molecule produced after vigorous exercise is responsible for the moderate weight loss caused by the diabetes medication metformin, according to a new study in mice and humans. The molecule, …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Bariatric tourism - 1 month(s) ago
Obtaining bariatric surgery in England is not easy. Even getting the initial referral can be a challenge. Francesco Rubino, Chair of Metabolic and Bariatric Surgery at King’s College London, London, UK, noted that a lot of a general practitioners (GPs) harbour the misconception that weight loss can simply be managed by the patient through some combination of willpower, diet, and exercise. “Even if a patient specifically asks to be referred to a bariatric centre, their GP still might say ‘first you need to try to eat better and be more active’”, said Rubino.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6Whether you exercise regularly or one-to-two days a week, weight loss is possible, shows study - 2 month(s) ago
Whether you engage in physical activity on a regular basis or one-to-two days a week, both options produce weight loss suggests a new study titled “The Associations of ‘Weekend Warrior’ and Regularly …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Most employer health plans don't cover new blockbuster weight loss drugs, but that's going to change - 2 month(s) ago
Weight loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound cost over $1,000 a month, and right now, most employer health insurance doesn’t cover it.
Source: www.cnbc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Shannon's Story | Weight Loss Patient Stories - 3 month(s) ago
After a lifelong struggle with weight management and insensitive providers, Shannon found solutions and respect at Henry Ford Medical Center – Plymouth.
Source: www.henryford.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0People Who Stopped Taking the Weight Loss Drug Tirzepatide Regained Nearly Half the Weight They Lost - 4 month(s) ago
A new study of tirzepatide, the main ingredient in Mounjaro and Zepbound, finds that weight loss gains are hard to maintain after treatment ends.
Source: www.everydayhealth.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3OABG Not Superior to RYGB for Weight Loss, Metabolism - 4 month(s) ago
One-anastomosis gastric bypass produces comparable weight loss and metabolic outcomes to Roux-en-Y gastric bypass, but it is less effective for other outcomes.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Login - 4 month(s) ago
New to DocMatter, or having trouble logging in? Click here to find your account Contact us for other issues, or Request to join.
Source: www.docmatter.comCategories: General Medicine News, EndocrinologyTweet
More evidence refutes link between #weightloss drugs, suicidal thoughts https://t.co/KiOEJ2arFa